What Is the Timing of General Health Adverse Events That Occur After Total Joint Arthroplasty?

Clinical Orthopaedics and Related Research

Volumn 475, Issue 12, 2017, Pages 2952-2959

  Bohl, Daniel D ^a   Ondeck, Nathaniel T ^b   Basques, Bryce A ^a   Levine, Brett R ^a   Grauer, Jonathan N ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; FEMALE; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPSIS; SURGICAL INFECTION; TOTAL ARTHROPLASTY; URINARY TRACT INFECTION; VERY ELDERLY; ADOLESCENT; DATA MINING; FACTUAL DATABASE; HEALTH CARE QUALITY; HIP REPLACEMENT; KNEE REPLACEMENT; LENGTH OF STAY; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; DATA MINING; DATABASES, FACTUAL; HUMANS; LENGTH OF STAY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT DISCHARGE; POSTOPERATIVE COMPLICATIONS; PROCESS ASSESSMENT (HEALTH CARE); PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 85008190846     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-016-5224-2     Document Type: Conference Paper

References (36)

1. Belmont PJ Jr, Goodman GP, Kusnezov NA, Magee C, Bader JO, Waterman BR, Schoenfeld AJ. Postoperative myocardial infarction and cardiac arrest following primary total knee and hip arthroplasty: rates, risk factors, and time of occurrence. J Bone Joint Surg Am. 2014;96:2025–2031.
2. Bohl DD, Basques BA, Golinvaux NS, Baumgaertner MR, Grauer JN. Nationwide Inpatient Sample and National Surgical Quality Improvement Program give different results in hip fracture studies. Clin Orthop Relat Res. 2014;472:1672–1680.
3. Bohl DD, Russo GS, Basques BA, Golinvaux NS, Fu MC, Long WD 3rd, Grauer JN. Variations in data collection methods between national databases affect study results: a comparison of the Nationwide Inpatient Sample and National Surgical Quality Improvement Program databases for lumbar spine fusion procedures. J Bone Joint Surg Am. 2014;96:e193.
4. Bohl DD, Shen MR, Kayupov E, Della Valle CJ. Hypoalbuminemia independently predicts surgical site infection, pneumonia, length of stay, and readmission after total joint arthroplasty. J Arthroplasty. 2016;31:15–21.
5. Browne JA, Novicoff WM, D’Apuzzo MR. Medicaid payer status is associated with in-hospital morbidity and resource utilization following primary total joint arthroplasty. J Bone Joint Surg Am. 2014;96:e180.
6. Cavanaugh PK, Chen AF, Rasouli MR, Post ZD, Orozco FR, Ong AC. Total joint arthroplasty in transplant recipients: in-hospital adverse outcomes. J Arthroplasty. 2015;30:840–845.
7. Crowe B, Payne A, Evangelista PJ, Stachel A, Phillips MS, Slover JD, Inneh IA, Iorio R, Bosco JA. Risk factors for infection following total knee arthroplasty: a series of 3836 cases from one institution. J Arthroplasty. 2015;30:2275–2278.
8. Duchman KR, Gao Y, Pugely AJ, Martin CT, Noiseux NO, Callaghan JJ. The effect of smoking on short-term complications following total hip and knee arthroplasty. J Bone Joint Surg Am. 2015;97:1049–1058.
9. Enayatollahi MA, Novack TA, Maltenfort MG, Tabatabaee RM, Chen AF, Parvizi J. In-hospital morbidity and mortality following total joint arthroplasty in patients with hemoglobinopathies. J Arthroplasty. 2015;30:1308–1312.
10. Florschutz AV, Fagan RP, Matar WY, Sawyer RG, Berrios-Torres SI. Surgical site infection risk factors and risk stratification. J Am Acad Orthop Surg. 2015;23(Suppl):S8–s11.
11. Goyal N, Chen AF, Padgett SE, Tan TL, Kheir MM, Hopper RH Jr, Hamilton WG, Hozack WJ. Otto Aufranc Award: A multicenter, randomized study of outpatient versus inpatient total hip arthroplasty. Clin Orthop Relat Res. 2016 Jun 10. [Epub ahead of print].
12. Khuri SF. The NSQIP: a new frontier in surgery. Surgery. 2005;138:837–843.
13. Kumar A, Tsai WC, Tan TS, Chiu LT, Kung PT, Lo CK, Ku MC. Risk of post-TKA acute myocardial infarction in patients with a history of myocardial infarction or coronary stent. Clin Orthop Relat Res. 2016;474:479–486.
14. Lovecchio F, Alvi H, Sahota S, Beal M, Manning D. Is outpatient arthroplasty as safe as fast-track inpatient arthroplasty? A propensity score matched analysis. J Arthroplasty. 2016;31:197–201.
15. Lu N, Misra D, Neogi T, Choi HK, Zhang Y. Total joint arthroplasty and the risk of myocardial infarction: a general population, propensity score-matched cohort study. Arthritis Rheumatol (Hoboken NJ). 2015;67:2771–2779.
16. Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL. Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. Anesthesiology. 2002;96:1140–1146.
17. Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL. Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty. Anesthesiology. 2003;99:552–560; discussion 555A.
18. Menendez ME, Memtsoudis SG, Opperer M, Boettner F, Gonzalez Della Valle A. A nationwide analysis of risk factors for in-hospital myocardial infarction after total joint arthroplasty. Int Orthop. 2015;39:777–786.
19. Molina CS, Thakore RV, Blumer A, Obremskey WT, Sethi MK. Use of the National Surgical Quality Improvement Program in orthopaedic surgery. Clin Orthop Relat Res. 2015;473:1574–1581.
20. Otero JE, Gholson JJ, Pugely AJ, Gao Y, Bedard NA, Callaghan JJ. Length of hospitalization after joint arthroplasty: does early discharge affect complications and readmission rates? J Arthroplasty. 2016;31:2714–2725.
21. Parvizi J, Huang R, Raphael IJ, Arnold WV, Rothman RH. Symptomatic pulmonary embolus after joint arthroplasty: stratification of risk factors. Clin Orthop Relat Res. 2014;472:903–912.
22. Parvizi J, Huang R, Raphael IJ, Maltenfort MG, Arnold WV, Rothman RH. Timing of symptomatic pulmonary embolism with warfarin following arthroplasty. J Arthroplasty. 2015;30:1050–1053.
23. Parvizi J, Mui A, Purtill JJ, Sharkey PF, Hozack WJ, Rothman RH. Total joint arthroplasty: when do fatal or near-fatal complications occur? J Bone Joint Surg Am. 2007;89:27–32.
24. Pedersen AB, Sorensen HT, Mehnert F, Overgaard S, Johnsen SP. Risk factors for venous thromboembolism in patients undergoing total hip replacement and receiving routine thromboprophylaxis. J Bone Joint Surg Am. 2010;92:2156–2164.
25. Ponnusamy KE, Jain A, Thakkar SC, Sterling RS, Skolasky RL, Khanuja HS. Inpatient mortality and morbidity for dialysis-dependent patients undergoing primary total hip or knee arthroplasty. J Bone Joint Surg Am. 2015;97:1326–1332.
26. Poultsides LA, Ma Y, Della Valle AG, Chiu YL, Sculco TP, Memtsoudis SG. In-hospital surgical site infections after primary hip and knee arthroplasty–incidence and risk factors. J Arthroplasty. 2013;28:385–389.
27. Pugely AJ, Martin CT, Harwood J, Ong KL, Bozic KJ, Callaghan JJ. Database and registry research in orthopaedic surgery: Part I: claims-based data. J Bone Joint Surg Am. 2015;97:1278–1287.
28. Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res. 2008;466:1710–1715.
29. Rasouli MR, Maltenfort MG, Purtill JJ, Hozack WJ, Parvizi J. Has the rate of in-hospital infections after total joint arthroplasty decreased? Clin Orthop Relat Res. 2013;471:3102–3111.
30. Rasouli MR, Restrepo C, Maltenfort MG, Purtill JJ, Parvizi J. Risk factors for surgical site infection following total joint arthroplasty. J Bone Joint Surg Am. 2014;96:e158.
31. Schiff RL, Kahn SR, Shrier I, Strulovitch C, Hammouda W, Cohen E, Zukor D. Identifying orthopedic patients at high risk for venous thromboembolism despite thromboprophylaxis. Chest. 2005;128:3364–3371.
32. Schilling PL, Hallstrom BR, Birkmeyer JD, Carpenter JE. Prioritizing perioperative quality improvement in orthopaedic surgery. J Bone Joint Surg Am. 2010;92:1884–1889.
33. Shiloach M, Frencher SK Jr, Steeger JE, Rowell KS, Bartzokis K, Tomeh MG, Richards KE, Ko CY, Hall BL. Toward robust information: data quality and inter-rater reliability in the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg. 2010;210:6–16.
34. Suleiman LI, Ortega G, Ong’uti SK, Gonzalez DO, Tran DD, Onyike A, Turner PL, Fullum TM. Does BMI affect perioperative complications following total knee and hip arthroplasty? J Surg Res. 2012;174:7–11.
35. Tabatabaee RM, Rasouli MR, Rezapoor M, Maltenfort MG, Ong AC, Parvizi J. Coronary revascularization and adverse events in joint arthroplasty. J Surg Res. 2015;198:135–142.
36. White RH, Gettner S, Newman JM, Trauner KB, Romano PS. Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty. N Engl J Med. 2000;343:1758–1764.